Stock listing
NYSE:BXLT Baxalta Inc Stock
Follow Baxalta Inc into a list and get an email when it puts out news.
Last close · NYSE:BXLT
$46.02 USD
Close on Jun 2, 2016 · No longer trades
- Lowest – highest close
- $30.06 – $46.20 USDSince Jul 1, 2015 · lowest Jul 9, 2015 · highest Jun 1, 2016
Delisted NYSE:BXLT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NYSE:BXLT
- Asset type
- Stock
- Exchange
- NYSE
- Currency
- USD
Baxalta Inc on 6ix
- Decks
- 8 decks · latest Apr 28, 2016
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q1 2016 Earnings Presentation | Earnings | 36 slides | Apr 28, 2016 |
| Merger or Acquisition (March 2016) | Merger or acquisition | 9 slides | Mar 18, 2016 |
| Q4 2015 Earnings Presentation | Earnings | 46 slides | Feb 16, 2016 |
| Merger or Acquisition (January 2016) | Merger or acquisition | 31 slides | Jan 12, 2016 |
| Merger or Acquisition (January 2016) | Merger or acquisition | 26 slides | Jan 11, 2016 |
| Q3 2015 Earnings Presentation | Earnings | 34 slides | Oct 29, 2015 |
| BAML Global Healthcare Conference 2015 | Conference | 19 slides | Sep 17, 2015 |
| Merger or Acquisition (August 2015) | Merger or acquisition | 22 slides | Aug 4, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| François Nader Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alexion Pharmaceuticals Inc (Director · Nov 15, 2017 – Jul 21, 2021 · Past); Acceleron Pharma Inc (Director · Dec 11, 2014 – Nov 19, 2021 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past) | Director · Jul 27, 2015 – Jun 3, 2016 · Past |
| Robert J. Hombach Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Henry Schein, Inc. (Director · Since at least Jan 29, 2025); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past) | EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past |
| Wayne T Hockmeyer Other companies: GenVec Inc (Director · Jun 16, 2010 – Jun 16, 2017 · Past); Idenix Pharmaceuticals Inc (Director · Jun 3, 2010 – Aug 5, 2014 · Past); Baxter International Inc. (Director · May 4, 2010 – May 5, 2015 · Past) | Director · Jun 9, 2015 – Jun 3, 2016 · Past |
| James R Gavin III Other companies: Baxter International Inc. (Director · Apr 19, 2010 – Sep 11, 2020 · Past); Amylin Pharmaceuticals LLC (Director · Apr 5, 2010 – Aug 8, 2012 · Past) | Director · Jul 1, 2015 – Jun 3, 2016 · Past |
Log in to ask 6ix AI your own questions about Baxalta Inc.